These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12215114)

  • 1. From the Food and Drug Administration.
    Crawford LM
    JAMA; 2002 Sep; 288(10):1225. PubMed ID: 12215114
    [No Abstract]   [Full Text] [Related]  

  • 2. New drug approved for colorectal cancer.
    FDA Consum; 2002; 36(5):2. PubMed ID: 12412532
    [No Abstract]   [Full Text] [Related]  

  • 3. Update: a 54-year-old woman with constipation-predominant irritable bowel syndrome.
    Farag N; Reynolds E; Lembo A
    JAMA; 2008 Jan; 299(1):88. PubMed ID: 18167409
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel medications for the irritable bowel syndrome: motility and sensation.
    Camilleri M
    J Pediatr Gastroenterol Nutr; 2001; 32 Suppl 1():S35-7. PubMed ID: 11321419
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
    Gale JD
    Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized trial of mosapride vs. placebo in constipation-predominant irritable bowel syndrome.
    Mansour NM; Ghaith O; El-Halabi M; Sharara AI
    Am J Gastroenterol; 2012 May; 107(5):792-3. PubMed ID: 22552247
    [No Abstract]   [Full Text] [Related]  

  • 7. A 54-year-old woman with constipation-predominant irritable bowel syndrome.
    Lembo AJ
    JAMA; 2006 Feb; 295(8):925-33. PubMed ID: 16493106
    [No Abstract]   [Full Text] [Related]  

  • 8. Highlights From: the 2006 American Society of Clinical Oncology Gastrointestinal Cancers Symposium San Francisco, CA, January 2006.
    Gibson TB; Ranganathan A; D'Orazio A;
    Clin Colorectal Cancer; 2006 Mar; 5(6):398-402. PubMed ID: 16635277
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA approves restricted marketing of Lotronex.
    FDA Consum; 2002; 36(4):4. PubMed ID: 12184306
    [No Abstract]   [Full Text] [Related]  

  • 10. A speedy approval.
    Schultz S
    US News World Rep; 2002 Aug 26-Sep 2; 133(8):26. PubMed ID: 12219556
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky.
    Horwitz BJ
    Health News; 2002 Oct; 8(10):1-2. PubMed ID: 12416480
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA approves one drug for irritable bowel syndrome but suspends another.
    Harv Womens Health Watch; 2008 Aug; 15(12):7. PubMed ID: 19115501
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxaliplatin in colorectal cancer: an overview.
    Armand JP; Boige V; Raymond E; Fizazi K; Faivre S; Ducreux M
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):96-104. PubMed ID: 11049040
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation.
    Tack J; Müller-Lissner S; Bytzer P; Corinaldesi R; Chang L; Viegas A; Schnekenbuehl S; Dunger-Baldauf C; Rueegg P
    Gut; 2005 Dec; 54(12):1707-13. PubMed ID: 16020489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of eloxatin for the treatment of widespread colorectal cancer].
    Miasoiedov DV; Ievtushenko OI; Iugrinov OH
    Klin Khir; 2001 Dec; (12):41-3. PubMed ID: 11944274
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oxaliplatin].
    Bascioni R
    Suppl Tumori; 2004; 3(4):S111-2. PubMed ID: 15206232
    [No Abstract]   [Full Text] [Related]  

  • 17. A historical perspective on oxaliplatin: rethinking the role of platinum compounds and learning from near misses.
    Cvitkovic E
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):1-3. PubMed ID: 9609102
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenomics in gastrointestinal disorders.
    Camilleri M; Saito YA
    Methods Mol Biol; 2008; 448():395-412. PubMed ID: 18370239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin (Eloxatin) for advanced colon cancer.
    Med Lett Drugs Ther; 2003 Jan; 45(1148):7-8. PubMed ID: 12571541
    [No Abstract]   [Full Text] [Related]  

  • 20. Peripherally acting therapies for the treatment of irritable bowel syndrome.
    Saad RJ
    Gastroenterol Clin North Am; 2011 Mar; 40(1):163-82. PubMed ID: 21333906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.